Polypid Ltd Net Income per Employee (PYPD), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Polypid Ltd  (NASDAQ: PYPD)
 

Polypid Ltd Net Income per Employee

PYPD's Quarterly Results, Trends, Rankings, Statistics
Polypid Ltd's Income per employee fell in the second quarter 2025 on a trailing twelve month basis to $ 322,797, below the company average number of $428,826.
The Healthcare sector has seen employees of 6 other companies achieving higher income per employee. While Polypid Ltd's total ranking has deteriorated compared to the previous quarter from 267 to 324.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PYPD Net Income per Employee (Jun 30 2025)
II. Quarter		 (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Net Income Change - 397.21 % - - -
Net Income per Employee (TTM) $ 322,797 491,898 98,932 769,390 769,390
PYPD's Total Ranking # 324 # 267 # 0 # 0 #
Seq. Net Income Change - - - - -

PYPD Company Profile >> Back to PYPD Efficiency Comparisons >> Compare PYPD Net Income per Employee to its Competitors

PYPD Net Income per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 7
Healthcare Sector # 35
Overall Market # 324

Net Income per Employee Statistics
High Average Low
$ 722,051 $ 428,826 $ -169,102
(Dec 31 2021)   (Jun 30 2025)







Companies with similar Income per Employee for 12 month ending Jun 30 2025, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2025Number of Employees Jun 30 2025
Novavax inc   564,518.02 $ 422.824  Million 749 
Rigel Pharmaceuticals Inc  562,189.66 $ 97.821  Million 174 
Engene Therapeutics Inc   525,500.00 $ 43.091  Million 82 
Amgen Inc   509,153.85 $ 6,619.000  Million 13,000 
Krystal Biotech Inc   497,372.88 $ 146.725  Million 295 
Nutriband Inc   483,137.20 $ 2.416  Million 5 
Aurinia Pharmaceuticals Inc   473,718.75 $ 60.636  Million 128 
Eledon Pharmaceuticals Inc   469,606.06 $ 15.497  Million 33 
Black Hawk Acquisition Corporation  433,992.50 $ 0.868  Million 2 
Atara Biotherapeutics Inc   413,928.57 $ 5.795  Million 14 
Protagonist Therapeutics inc   394,227.27 $ 52.038  Million 132 
Gilead Sciences Inc   371,235.29 $ 6,311.000  Million 17,000 
Adma Biologics Inc   322,918.08 $ 208.928  Million 647 
Stoke Therapeutics Inc   308,729.41 $ 52.484  Million 170 
Incyte Corporation  306,213.08 $ 870.870  Million 2,844 
Regeneron Pharmaceuticals Inc   289,331.60 $ 4,458.600  Million 15,410 
Acadia Pharmaceuticals Inc   278,395.99 $ 222.160  Million 798 
Eli Lilly And Company  275,998.00 $ 13,799.900  Million 50,000 
Puma Biotechnology Inc   270,675.98 $ 48.451  Million 179 
Dariohealth Corp   267,751.52 $ 44.179  Million 165 
Entera Bio Ltd   267,545.45 $ 5.886  Million 22 
Cytodyn inc   267,500.00 $ 3.745  Million 14 
Semnur Pharmaceuticals Inc   266,189.61 $ 10.115  Million 38 
Edwards Lifesciences Corporation  258,850.00 $ 4,141.600  Million 16,000 
Abeona Therapeutics Inc   253,283.19 $ 57.242  Million 226 
Arcutis Biotherapeutics Inc   249,084.75 $ 88.176  Million 354 
Innoviva Inc   243,075.47 $ 38.649  Million 159 
Keros Therapeutics Inc   240,679.49 $ 18.773  Million 78 
Lantheus Holdings Inc   227,160.94 $ 271.003  Million 1,193 
Merck and Co Inc   218,906.67 $ 16,418.000  Million 75,000 


Date modified: 2026-07-07T12:42:51+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.